Ascil Biopharm

Ascil Biopharm is a clinical-stage biotechnology company specializing in innovative drug delivery solutions. We operate as a CDMO, fully equipped for early-stage drug product development, with a GMP facility for clinical batch manufacturing,(aseptic process and terminal sterilization) to fill various containers (e.g. vials, syringes). Our capabilities extend to formulation, device, and analytical development. · Our proprietary Controlled-Release Formulation (CRF) platform technology, is designed to improve the Phy-Chem properties of APIs and excipients under injection conditions, enabling the development of ready-to-use (RTU) controlled-release formulations and ultra-high concentration (UHC) drug products. · Our expertise covers a wide range of molecules, from small molecules to biologics, with a particular focus on peptides, proteins, fusion proteins, toxins, and monoclonal antibodies (mAbs). We work on both internal and external assets across endocrine, oncology, infectious, dermatological, ocular, supporting projects from preclinical to clinical stages.